Apotheek As: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Apotheek As
Largest movements
- Current investments -€180,000
down €180,000 (-95.4%), from €188,657 to €8,657
- Receivables within one year +€83,596
up €83,596 (+42.7%), from €195,760 to €279,356
of which Other amounts receivable: +€75,741
- Cash +€42,608
up €42,608 (+22.4%), from €190,462 to €233,070
mainly Current investments (+€180,000) and Short-term financial debts (+€125,000)
- Stocks and contracts +€14,885
up €14,885 (+7.1%), from €210,709 to €225,595
- Other debts -€132,426
down €132,426 (-54.0%), from €245,376 to €112,950
- Short-term financial debts +€125,000
new in 2025: €125,000
- Reserves -€64,204
down €64,204 (-31.4%), from €204,338 to €140,134
- Trade debts +€41,383
up €41,383 (+27.4%), from €151,249 to €192,632
- Debts after one year -€10,955
down €10,955 (-6.0%), from €183,404 to €172,448
- Gross operating margin -€60,109
down €60,109 (-32.7%), from €183,690 to €123,582
- Financial income -€14,876
down €14,876 (-82.1%), from €18,111 to €3,235
- Financial charges -€12,247
down €12,247 (-48.8%), from €25,106 to €12,859
- Staff costs +€2,777
up €2,777 (+5.1%), from €54,039 to €56,816
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €830,739 | €783,998 | -€46,741 | -5.6% |
| Fixed assets | 21/28 | €43,270 | €36,981 | -€6,290 | -14.5% |
| Tangible fixed assets | 22/27 | €43,270 | €36,981 | -€6,290 | -14.5% |
| Land and buildings | 22 | €12,899 | €12,881 | -€18 | -0.1% |
| Plant, machinery and equipment | 23 | €14,285 | €13,674 | -€612 | -4.3% |
| Furniture and vehicles | 24 | €10,249 | €7,696 | -€2,553 | -24.9% |
| Other tangible fixed assets | 26 | €5,838 | €2,730 | -€3,107 | -53.2% |
| Current assets | 29/58 | €787,469 | €747,018 | -€40,451 | -5.1% |
| Stocks and contracts in progress | 3 | €210,709 | €225,595 | +€14,885 | +7.1% |
| Stocks | 30/36 | €210,709 | €225,595 | +€14,885 | +7.1% |
| Amounts receivable within one year | 40/41 | €195,760 | €279,356 | +€83,596 | +42.7% |
| Trade receivables | 40 | €168,905 | €176,760 | +€7,855 | +4.7% |
| Other amounts receivable | 41 | €26,855 | €102,597 | +€75,741 | +282% |
| Current investments | 50/53 | €188,657 | €8,657 | -€180,000 | -95.4% |
| Cash at bank and in hand | 54/58 | €190,462 | €233,070 | +€42,608 | +22.4% |
| Deferred charges and accrued income | 490/1 | €1,880 | €340 | -€1,540 | -81.9% |
| Total equity and liabilities | 10/49 | €830,739 | €783,998 | -€46,741 | -5.6% |
| Equity | 10/15 | €222,938 | €158,734 | -€64,204 | -28.8% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €204,338 | €140,134 | -€64,204 | -31.4% |
| Distributable reserves | 133 | €204,338 | €140,134 | -€64,204 | -31.4% |
| Profit (loss) carried forward | 14 | €0 | €0 | = | |
| Amounts payable | 17/49 | €607,802 | €625,265 | +€17,463 | +2.9% |
| Amounts payable after more than one year | 17 | €183,404 | €172,448 | -€10,955 | -6.0% |
| Financial debts | 170/4 | €183,404 | €172,448 | -€10,955 | -6.0% |
| Amounts payable within one year | 42/48 | €416,898 | €452,816 | +€35,918 | +8.6% |
| Current portion of amounts payable after more than one year | 42 | €10,586 | €10,955 | +€369 | +3.5% |
| Financial debts | 43 | - | €125,000 | +€125,000 | |
| Credit institutions | 430/8 | - | €125,000 | +€125,000 | |
| Trade debts | 44 | €151,249 | €192,632 | +€41,383 | +27.4% |
| Suppliers | 440/4 | €151,249 | €192,632 | +€41,383 | +27.4% |
| Taxes, remuneration and social security | 45 | €9,687 | €11,279 | +€1,592 | +16.4% |
| Taxes | 450/3 | €1,691 | €969 | -€721 | -42.7% |
| Remuneration and social security | 454/9 | €7,996 | €10,310 | +€2,314 | +28.9% |
| Other amounts payable | 47/48 | €245,376 | €112,950 | -€132,426 | -54.0% |
| Accrued charges and deferred income | 492/3 | €7,500 | €0 | -€7,500 | -100% |
| Non-recurring operating income | 76A | €0 | - | = | |
| Remuneration, social security and pensions | 62 | €54,039 | €56,816 | +€2,777 | +5.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €9,018 | €8,142 | -€877 | -9.7% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €770 | +€770 | |
| Other operating charges | 640/8 | €5,365 | €4,098 | -€1,267 | -23.6% |
| Gross operating margin | 9900 | €183,690 | €123,582 | -€60,109 | -32.7% |
| Operating profit (loss) | 9901 | €115,268 | €53,756 | -€61,513 | -53.4% |
| Financial income | 75/76B | €18,111 | €3,235 | -€14,876 | -82.1% |
| Recurring financial income | 75 | €18,111 | €3,235 | -€14,876 | -82.1% |
| Financial charges | 65/66B | €25,106 | €12,859 | -€12,247 | -48.8% |
| Recurring financial charges | 65 | €25,106 | €12,859 | -€12,247 | -48.8% |
| Profit (loss) for the period before taxes | 9903 | €108,273 | €44,131 | -€64,142 | -59.2% |
| Income taxes | 67/77 | €2,041 | €1,389 | -€652 | -31.9% |
| Profit (loss) for the period | 9904 | €106,232 | €42,742 | -€63,490 | -59.8% |
| Profit (loss) for the period to be appropriated | 9905 | €106,232 | €42,742 | -€63,490 | -59.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.